that's generally right but a single patient is unlikely to have multiple cancer types. It will be one cancer type that has spread to multiple sites
- Forums
- ASX - By Stock
- Ann: Phase II study for indication expansion of TLX250-CDx doses
that's generally right but a single patient is unlikely to have...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$18.15 |
Change
0.600(3.42%) |
Mkt cap ! $6.073B |
Open | High | Low | Value | Volume |
$17.80 | $18.15 | $17.63 | $14.74M | 822.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1200 | $18.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.18 | 3850 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1970 | 19.050 |
1 | 25 | 18.200 |
2 | 64 | 18.180 |
2 | 1006 | 18.150 |
1 | 200 | 18.130 |
Price($) | Vol. | No. |
---|---|---|
17.250 | 2804 | 1 |
17.460 | 1015 | 4 |
17.470 | 340 | 1 |
17.510 | 775 | 1 |
17.600 | 620 | 1 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |